Tolvaptan Production Cost Reports

The report provides a detailed analysis essential for establishing a Tolvaptan production plant. It encompasses all critical aspects necessary for Tolvaptan production, including the cost of Tolvaptan production, Tolvaptan plant cost, Tolvaptan production costs, and the overall Tolvaptan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tolvaptan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tolvaptan is a medicine that helps the body get rid of extra water. It is used to treat hyponatremia (low sodium levels in the blood) associated with conditions like congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

It works by blocking the action of vasopressin in the kidneys, which increases the excretion of free water without losing electrolytes. This raises serum sodium levels and reduces fluid overload. It is also used to slow the decline of kidney function in adults at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). It helps manage fluid balance and sodium concentration in the body, making it valuable in treating disorders that lead to fluid retention and low blood sodium. It is administered orally, and its common side effects include increased thirst, dry mouth, frequent urination, headache, nausea, constipation, and tiredness.

The Tolvaptan market is driven by the rising prevalence of autosomal dominant polycystic kidney disease (ADPKD) and hyponatremia. The increasing demand for targeted therapies, advancements in drug formulations, and expanded healthcare infrastructure boost its market. The growth in chronic kidney disease makes it a popular medication in a broad patient base.

The industrial Tolvaptan procurement is affected by regulatory challenges (concerns about liver toxicity), high production costs, raw material availability (7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine, sodium borohydride, etc.), etc. The market is also influenced by regional healthcare policies, increasing awareness of kidney diseases, and ongoing innovation in treatment options. North America leads its market due to advanced healthcare systems, while Asia-Pacific is growing because of rising diagnosis rates and healthcare investments.

Raw Material for Tolvaptan Production

According to the Tolvaptan production plant project report, the key raw materials used in the production of Tolvaptan include (7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1H-1-Benzazepine)- Sodium Borohydride-Methanol-Methylene Chloride, Petroleum Ether.

Production Process of Tolvaptan

The extensive Tolvaptan production cost report consists of the following major industrial production process:

• From 7-Chloro-5-Hydroxy-2,3,4,5-Tetrahydro-1H-1-Benzazepine: The production process of Tolvaptan involves several steps. First, 7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine is reduced in methanol using sodium borohydride as the reducing agent. The mixture is stirred for 2 hours at 0 degree until the reaction completes. The reaction mixture is then poured into water and extracted with methylene chloride. The organic layer is dried over anhydrous sodium sulfate, filtered, and the solvent removed under reduced pressure. The crude product is purified by vacuum distillation using a solvent system of methanol and petroleum ether to pure Tolvaptan as the final product.

Tolvaptan has a molecular formula of C26H25ClN2O3 and a molecular weight of 448.94 g/mol. It is almost insoluble in water across all pH ranges but is slightly soluble in ethyl acetate. It is sparingly soluble in ethanol, soluble in methanol, and freely soluble in benzyl alcohol. It has a melting point between 219-222 degree Celsius and a boiling point around 594 degree Celsius. It has a density of around 1.311 g/cm³. Its octanol water partition coefficient is greater than 5000, which makes it highly lipophilic. It is stable under recommended storage conditions (2-8 degree Celsius) and exists as a racemic mixture. All these physical and chemical properties make it useful as a selective vasopressin V2-receptor antagonist, which is useful in treating conditions like hyponatremia and autosomal dominant polycystic kidney disease (ADPKD).